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Abstract 
Bone is mainly composed of supporting cells, organic matrix (made up of collagen 
and noncollagen proteins), and inorganic mineral (deposited within the matrix). The 
quality of bone mainly depends on its structural and material properties which 
include bone mineralization, collagen properties and element distribution. As a 
common chronic skeletal disorder, osteoporosis (OP) leads to the increased risk of 
bone fractures. OP is characterized by reduced bone mass and density and altered 
micro-architecture. To investigate the degree of mineralization of bone and bone 
mineral density distribution, advanced microscopes and analytical facilities have 
been applied to observe the morphology and structure of bone at micro and nano 
scale and measure the composition even at trace level. 
The aims of this study were to apply analytical facilities to investigate the influence 
of osteoporosis in maxillary bone of ovariectomized rats in both newly formed and 
mature (old) bone area, and to further optimise the experimental conditions for future 
relevant analytical studies. The maxillary bone samples were collected from normal 
(Sham) and ovariectomized (Ovx) rat models. The composition of mineral was 
measured by energy-dispersive X-ray spectroscopy (EDS) combined with scanning 
electron microscopy (SEM). The distribution of trace elements was measured by 
laser ablation inductively coupled plasma mass spectrometer (LA-ICP-MS). The 
structure of collagen and mineral crystal was observed and investigated by 
transmission electron microscope (TEM) and selected area electron diffraction 
(SAED) patterns.  
The results of EDS showed that the ratio of Ca/P in maxillary bone was comparable 
between the Ovx and Sham groups, while the observation by TEM and SAED 
patterns demonstrated that mineral mono crystallites might exist in the Ovx group. 
Using LA-ICP-MS, the concentrations of Zn was detected higher in normal bone 
than osteoporotic bone. The concentrations of Zn, Sr and Pb were higher in mature 
(old) bone than in newly formed bone while the concentration of Fe was lower in 
both the Sham and Ovx groups. In this study, the difference of metallic and non-
metallic elements in ovariectomy-induced osteoporosis tibia (trabecular bone), 
maxilla (cortical bone) and normal bone was also investigated by LA-ICP-MS. It was 
 Analytical Study of Osteoporosis of Maxilla in Ovariectomized Rats iii
noted that the concentrations of 
28
Si, 
77
Se, 
208
Pb, and Ca/P ratio were higher in tibia 
and maxilla in osteoporotic rats than those in normal bone at all evaluated time-
points.  The average concentrations of 
25
Mg, 
28
Si, 
39
K, 
47
Ti, 
56
Fe, 
59
Co, 
66
Zn, 
77
Se, 
88
Sr, 
137
Ba, and 
208
Pb were generally higher in tibia than those in maxilla, indicating 
tibial trabecular bones may be more sensitive to the change of estrogen than 
maxillary cortical bones.  
This study demonstrated that the composition of mineral in maxilla was similar 
between Ovx and Sham groups; however, the changes of maxilla after Ovx treatment 
occurred in the trace elements and ultrastructure at the nano-scale during bone 
maturation.  
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1.1 BACKGROUND 
Skeletal bone, featured in rigidity and hardness, is an important connective tissue 
which is not only protecting and supporting the body structures but also acting as a 
mineral reservoir for calcium and phosphorus homeostasis [1]. Bone is chiefly 
composed of supporting cells (osteoblasts, osteoclasts and osteocytes) and the 
organic matrix made up of collagen and noncollagen proteins, with the inorganic 
mineral deposited within the matrix [1]. The major inorganic component of bone is 
the mineral in the osteoid matrix, a crystalline complex of calcium and phosphate, 
which determines the hardness and rigidity of bone. The organic matrix of bone is 
mainly constituted of type I collagen and the noncollagen matrix proteins [1, 2].  
The quality of bone mainly depends on the structure of bone such as whole bone 
geometry and cortical microarchitecture, and the material properties which include 
bone mineralization, collagen properties and micro-damages [3, 4]. To maintain 
optimal bone quality, both mineral and collagen contribute to the material properties 
of bone [5]. The two major components of bone, collagen and mineral are well 
organized. Although bone tissue strength and stiffness depends heavily on mineral 
content [6], collagen plays an equally important role in bone structural integrity as it 
primarily provides the tensile strength [7]. 
As the most abundant collagen in bone, type I collagen comprises the majority of the 
organic matrix. It is composed of three polypeptide chains and individual collagen 
helices are cross-linked within and between other collagen helices increasing their 
strength [5]. The patterns of gap and overlap regions within the fibrils - generated by 
the cross-linked collagen allow - the mineral crystals to deposit and make collagen a 
structural template for mineralization [8]. 
Bone mineralization is a process characterized by the deposition of mineral crystals 
on the collagenous matrix. The process involves both chemical and physical 
procedures, implying a combined action among the mineral, the organic matrix, and 
the cells [9] [10]. Bone mineralization depends on the presence of calcium, 
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phosphate, trace elements, and bone related proteins such as alkaline phosphatase; 
forming the mineralized tissues of bone by the deposition of mineral crystals on the 
template of collagen I [5].  
Bone mineral crystals are similar to geologic mineral hydroxyapatite (HA) but much 
smaller in size. The HA (Ca10(PO4)6(OH)2) crystal is a long platelet-shaped crystal 
which is responsible for bone strength  [11]. The crystals are arranged parallel to 
each other and the long axis of the crystal referred to as the “c” axis is parallel to the 
longitudinal axis of collagen fibrils under normal physiological condition [8]. The 
bone mineral crystals can contain surface impurities that the Ca
2+
, PO4
3–
 ions and 
OH
–
 of bone mineral crystal can be substituted by certain ions and anions [9]. This 
phenomenon makes the crystals more soluble and plays an important role in bone 
remodelling and mineral homeostasis [12]. However, this process can potentially be 
disturbed by certain systematic diseases, especially osteoporosis [12]. 
Osteoporosis (OP), a common chronic skeletal disorder, leads to the increased risk of 
bone fractures characterized by reduced bone mass and density and altered trabecular 
micro-architecture [13]. Bone fractures are the most common and dangerous problem 
associated with osteoporosis and can occur in almost all bones [14, 15]. Osteoporotic 
bone loss occurs most frequently in postmenopausal women and older people [16]. 
Postmenopausal osteoporosis is commonly related to an increase of unbalanced bone 
remodelling [17]. At the tissue level, osteoporosis is characterized with low bone 
mineral density (BMD) which is associated with the microarchitectural deterioration 
of bone [18]. Despite the fact that a decrease in mean BMD is well documented in 
postmenopausal osteoporotic women, the association between the risks of fragility 
fracture with a particular mineralization pattern remains unclear [19]. At the crystal 
level, altered distribution of the mineral characteristics has been reported in 
osteoporotic patients with either high or low remodelling [20]. Multiple studies of 
bone collagen from human postmenopausal osteoporosis and in ovariectomized 
(Ovx) models have shown that the concentration of enzymatically derived crosslinks 
is greatly reduced when compared with the controls [21, 22].  
In addition to the distribution and structure of mineral and collagen, trace elements 
also play a critical role in maintaining bone quality as each of the interacting 
chemical components of the mineral crystals can be exchanged with other competing 
ions from the surrounding matrix in vivo [23]. Bivalent metal ions such as 
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magnesium, strontium, zinc, barium, cobalt, nickel, manganese and lead ions can 
substitute calcium ions. The trivalent phosphate anions can be substituted by other 
species, such as bisphosphonates or pyrophosphate. The univalent hydroxyl moiety 
can also be substituted by other ions, such as fluoride or bromide [24]. It has been 
reported that osteoporosis and aging are coupled with increased magnesium content 
and decreased fluoride, acid phosphate, boron, strontium, and carbonate contents 
[25].  
Various techniques can be utilised to investigate the degree of mineralization of bone 
and bone mineral density distribution. Advanced microscopes and analytical 
facilities have also been used to observe the morphology and structure of bone at 
micro and nano scale and to measure the composition even at trace level. Bone 
geometry can be analysed using radiographs, dual X-ray absorptiometry (DXA) and 
clinical computed topography (CT) [26]. Vibrational spectroscopic methods such as 
infrared and Raman techniques could generate information on the chemical 
environment and structural detail of the mineral and collagen present in bone [27, 
28]. Energy-dispersive X-ray analysis (EDX) can generate the information necessary 
to determine the chemical composition of the specimen surface [9, 29]. Using 
transmission electron microscopy (TEM), the shape and size of the collagen fibres 
and mineral crystals can be visualized. Furthermore, selected area electron 
diffraction (SAED), can generate characteristic patterns which are then utilized to 
measure the composition and crystallite size of mineral crystals [30]. However, there 
is no comparable systematic observation analysis on the changes of collagen and 
mineralised tissues of osteoporosis, especially in the maxilla region, using all these 
advanced techniques available.  
 
1.2 PURPOSES 
The purpose of this study is to investigate the influence of osteoporosis in maxillary 
bone in an ovariectomized rat model using analytical facilities, and to optimise the 
relevant analytical methods to characterize small bone samples for future application 
of these advanced tools. 
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2.1 BASIC BONE BIOLOGY  
2.1.1 Physiology of Bone 
Skeletal bone is an organ type, which by virtue of its rigidity and hardness, supports 
and protects the body and provides points of attachment for skeletal muscles. Bones 
also have the ability to regenerate and repair. Besides protecting the vital organs, 
bone acts as a mineral reservoir for calcium and phosphorus homeostasis, as a 
reservoir of growth factors and cytokines, and provides an environment for marrow. 
The majority of bone is composed of supporting cells named osteoblasts, osteoclasts 
and osteocytes, the collagen and noncollagen proteins, along with the nonorganic 
mineral deposited within the matrix [1]. 
The composition of bone constitutes of 69% inorganic component and 22% organic 
component while the remainder is water. The hardness and rigidity of bone is due to 
the mineral in the osteoid matrix, a crystalline complex of calcium and phosphate 
that constitutes 99% of the inorganic component. Type I Collagen constitutes 90–
95% of the organic structural protein of bone and the remaining noncollagen matrix 
proteins including proteoglycans, sialoproteins, glacontaining proteins, and 2HS-
glycoprotein [1, 2]. 
There are two types of bone. The first type is cortical bone, which is also called 
compact bone and has a more compact structure as its name suggests. The second 
type is trabecular bone which has a spongy appearance and as a result it often called 
spongy or cancellous bone [31]. Cortical bones are dense and solid and form the 
outer layer of the bone. Trabecular bones make up the inner layer of the bone and 
have a “porotic”, honeycomb-like structure [32]. 
Both cortical and trabecular bones are composed of osteons which are lamellar 
structures [33]. Human bones can also be classified into four different kinds based on 
the shape: long bones, short bones, flat bones, and irregular bones. The ratio of 
cortical to trabecular bones differs in different kinds of bone [31]. 
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2.1.2 Bone Remodelling and Bone Cells 
The skeleton undergoes constant remodeling throughout a lifetime. The remodeling 
process relies on the activities of osteoclasts to remove mineralized bone and 
osteoblasts to form an extracellular matrix which is subsequently mineralized. Bone 
remodeling allows the bone to adjust to changing biomechanical forces. It removes 
old micro-damaged bone and replaces it with newly formed bone to help maintain 
the overall strength of bone [34].  
Bone remodeling can be divided into the following six phases: quiescent, activation, 
resorption, reversal, formation, and mineralization. These phases occur at random 
sites but also at areas that require repair [35, 36]. The bone that is resorbed and 
formed remains balanced after the remodeling cycle is completed [1]. 
Osteoblasts and osteoclasts hold responsibility for the dynamic balance of bone 
remodeling. Remodeling requires bone formation and bone resorption to function 
together during health and disease [37]. Most of the proteins of the bone matrix, 
including type I collagen and non-collagenous proteins, are synthesized and secreted 
by osteoblasts [38]. Osteoclasts, which carry out the process of resorption, are 
specialized as multinucleated cells [38].  
Osteoblasts are derived from mesenchymal stem cells whose function is in the 
synthesis and mineralization of bone. They stimulate the production of basic calcium 
phosphate crystals of hydroxyapatite in the matrix vesicles and deposit 
hydroxyapatite mineral crystal on the collagenous extracellular matrix [39].  
Osteoclasts are derived from the monocyte/macrophage lineage of the bone marrow, 
and play a dominant role in resorbing both the organic and inorganic matrices of 
bone. As highly specialized cells, osteoclasts are of great importance in regulating 
bone remodeling [37]. 
Osteocytes are the most abundant bone cells and are derived from osteoblasts 
embedded in the material that they synthesize [40, 41]. Osteocytes establish 
connections with neighbouring cells and bone surfaces by their dendrites [42, 43]. 
Osteocytes have multiple functions and by translating mechanical strains into 
biochemical signals they coordinate the complex interaction between bone formation 
and resorption which is carried out by osteoblasts and osteoclasts on the bone surface 
[44-47]. 
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2.1.3 Jaw Bone 
The jaw bone is a set of two bones, the upper jaw which is called the maxilla and the 
lower jaw which is called the mandible. To further subdivide, both the maxilla and 
mandible bone are composed of basal bone and alveolar bone. Classified as an 
irregular bone, jaw bone provides the frame for the oral cavity and is capable of 
holding the teeth within the alveolar bone [31, 48]. The mandible bone is a U-shaped 
bone and composed of two paired bones which join at the midline. It supports the 
teeth of the lower dental arch. The mandible bone is the only movable bone of the 
facial skeleton and is essential for movement of the mouth [49]. The maxilla is 
formed by two separate bones that fuse together and each half of the bone contains 
four processes—zygomatic, frontal, alveolar, and palatine [50].The maxilla bone 
forms most of the upper face, roof of the mouth. It assists in the formation of base of 
the nasal cavity and floor of the orbit [51]. The maxilla supports the upper teeth and 
is joined to other bones of head [50].  
An important difference between jaw bone and long bone is the mode of ossification. 
There are two primary mechanisms involved in bone formation: endochondral and 
intramembranous ossification. Endochondral ossification, a characteristic of long 
bone, requires a cartilaginous template for calcification of bone, including a series of 
formation and degradation processes for the cartilaginous framework. On the other 
hand, without the requirement of the cartilaginous element, intramembranous 
ossification, a characteristic of jaw bone, depends on the condensation of 
mesenchymal cells at the ossification centre [52, 53]. Forming part of the 
craniofacial bones, which ossify via intramembranous ossification, jaw bone follows 
similar embryological development [52]. 
 
2.2 PROCESS OF BIOMINERALIZATION IN PHYSIOLOGICAL 
CONDITION 
2.2.1 Biomineralization 
Biologic mineralization is a process involving both physical and chemical procedures 
characterised by the deposition of inorganic crystal like minerals on an organic 
matrix like collagen in an intracellular or extracellular way, implying a combined 
action among the mineral, the organic matrix and the cells [9]. 
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In hard tissues like bone or dentin, collagen works as the template of mineral 
deposition and mineral crystals deposit on a collagenous matrix forms the initial 
calcification centre for the further growth of crystal and tissue mineralization [10, 
54]. The crystal size as well as the site of initial crystal deposition is determined by 
the association of fibrillar collagen with the distribution and post-translational 
modification of extracellular matrix molecules [9, 55]. There are a number of ways 
the mineralization process is controlled, including regulation the concentrations of 
local calcium and phosphate along with pH [56, 57], and the synthesis and post-
translational modification of collagen and noncollagenous proteins [55].  
 
2.2.2 Hydroxyapatite 
Hydroxyapatite is a kind of crystal that is mainly responsible for bone strength. The 
long axis of the hydroxyapatite crystal is referred to as the “c” axis with the thickness 
is the “a” axis and the width is the “b” axis (Figure 1).  
 
 
 
 
 
 
 
 
 
The organization of nano-sized, platelet-shaped mineral crystallites in bone tissue is 
determined by the structural properties of the organic matrix [58]. Neighbouring 
collagen molecules, which are assembled with an axial shift of D≈67 nm, generate a 
pattern of gap and overlap regions within the fibrils. During bone formation the 
mineral crystals are arranged parallel to each other, developing along the “c” axis 
which has the same orientation as the longitudinal axis of collagen fibre. The mineral 
Figure 1 Crystal lattice structure. A portion of the apatite structure is depicted with a 
view along the length (c axis) of the hydroxyapatite crystal, showing the hexagonal 
arrangement of the Ca
2+
 and PO4
3–
 ions about the OH
–
 position [11].  
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crystals thicken by growing at the “a” and “b” axes [8]. Crystal nucleation triggered 
by collagen and by non-collagenous proteins also regulates several steps of 
mineralization. The crystals are elongated in a plate-like shape first, and then grow in 
thickness rather than in length [19, 59]. 
In physiologically mineralized tissues, like bone and dentin, the minerals are 
deposited in an oriented way on a collagen template that is similar to the geologic 
mineral hydroxyapatite (Ca10(PO4)6(OH)2). Physiologic mineral crystals at a 
microscopic level are less than 20 nm in size whereas geologic hydroxyapatite 
crystals are large enough to be visible to the naked eye. Mineral crystals can have a 
number of surface impurities and defects under physiological conditions (Figure 2), 
which is due to their small size and relatively large surface area [9].  
 
 
 
 
 
 
 
The imperfections of physiologic mineral crystal normally reduce the size and can 
determine how perfectly the mineral grows, making the crystals more soluble. This 
process allows for bone remodelling and can assist in the maintenance of mineral 
homeostasis [9, 56]. Moreover, this solubility also enables bone mineral to play an 
important role in Ca
2+
, Mg
2+
, and PO4
3− 
ion homeostasis [12].  
Biologic mineral crystal deposits on the initially mineralized tissues under certain 
physiological conditions only. This process is disabled by various mineralization 
inhibitors that avoid new deposition, protecting the cells from trapping in mineral. 
They can also modulate the size and shape of the crystals growing in body fluids and 
tissues. These inhibitors include anions that chelate calcium, such as, ATP, citrate, 
pyrophosphate and glycosaminoglycans, as well as proteins that specifically bind to 
mineral crystals, such as fetuin, albumin, osteopontin, osteonectin, and matrix-gla-
protein [60].  
Figure 2 The hydroxyapatite unit cell showing the major substituents that can occur 
in biologic apatites and the ions for which they are substituted. 
 Chapter 2: Literature Review 9 
2.2.3 Bone Mineralization 
Bone mass is highly correlated with the biomechanical quality of bone, the 
hierarchical structure and optimization of bone tissues at all levels. From the micro 
and nano range to the macro level, the outstanding mechanical properties of bone are 
organised and regulated [61]. Relevant factors can affect bone strength, including 
material properties of the organic matrix, mineralization density, architecture, 
geometry and shape, as well as pathological situation. Therefore, bone quality could 
be affected by alterations in a number of the factors that are involved in the process 
of bone remodeling [61, 62].  
The mechanisms of bone mineral crystal growth can be taken as a four-stage 
development. At the first step of crystal formation ions are adsorbed onto collagen 
fibrils, leading to the nucleation and formation of nanometre-sized particles. With 
further ionic deposition, the stable critical nucleuses grow. The direction of growth is 
dictated by the collagen and the neighbouring particles. These particles fuse together 
because of space restrictions and the resulting plate-like crystal presents [63]. The 
initially deposited apatites are brittle and crumbly because of their amorphous 
structure which is noncrystalline [64]. Mineralization majorly determines the 
maximal strength and stiffness of bone. The properties that reflect bone conversely 
correlate with toughness [65]. 
The two major components of bone are microfibrils of collagen and crystallites of 
bioapatite which are well organized into arrays even at the nanometer scale. The ratio 
of mineral/collagen in entire bone can also be established at this nanoscale level. 
This shows that bone exhibits a hierarchical structure that is well organized at several 
spatial scales [66-68]. Apatite crystallites of different sizes nucleate on and grow 
within the collagen network in two different gaps of microfibril structures. Larger 
apatite crystallites form in the larger “holes” structure located between the opposing 
ends of collagen microfibrils and smaller apatite crystallites form in smaller “pores” 
found between side-by-side collagen microfibrils (Fig.3). The apatite crystals 
propagate along their c-axes which are parallel to the longitudinal axis of the 
microfibril. Bone tissue is composed of several kinds of functional bone cells and 
complex extracellular matrix (ECM). Bone cells synthesize organic and inorganic 
molecules in an autocrine or paracrine mode, with these local molecules strictly 
regulating the process of bone calcification. Some other circulating factors that act in 
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feedback loops as endocrine hormones also ensure normal bone calcification [43, 
69]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Sketches of the hierarchical levels of typical cortical bone, e.g. in a femur. (A) 
Longitudinal section of long bone. (B) Enlargement of a cross-sectional slice of cortical 
bone. (C) Enlargement of one osteon, consisting of a central vascular cavity, concentric 
circles, and thin radiating lines. (D) One collagen fiber, created by the bundling of 
hundreds of fibrils, forms the structural framework of bone. (E) The smallest unit of the 
organic component in bone is the triple-helix collagen molecule. (F) Enlargement of 
collagen microfibrils. (G) Individual platelet of bioapatite. Bioapatite platelets are only 
about 2–3 unit cells thick. (H) View of the atomic structure of apatite, viewed down the c-
axis. Yellow = calcium atoms; red = oxygen; dark blue = phosphate tetrahedra; light 
blue = hydroxyl in channel sites [68].  
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The mineral ions, especially calcium and phosphate presenting in the form of H2PO4
-
 
and HPO4
2-
, play a vital part in biological activities. Phosphate is one of the main 
components of cellular structures and functions and is stored in the skeleton bone. It 
is circulated in the form of calcium-phosphate complex [69-71]. Specifically 80-85% 
of the total phosphorous distribution within the body occurs in bone [70, 71].  
 The factors involved in the regulation of phosphate homeostasis also play an 
important role in the bone mineralization process. Research has demonstrated that 
the calciotropic hormones parathyroid hormone (PTH) and 1, 25- dihydroxyvitamin 
D3 (1, 25(OH)2D3) greatly mediate the regulation of phosphate homeostasis [69].  
Pyrophosphate (PPi), consisting of two molecules of inorganic phosphate (Pi) joined 
by a hydrolyzable high-energy ester bond, is distributed in both intra- and 
extracellular compartments and body fluids [72, 73]. Extracellular PPi deficiency 
could lead to excessive mineral development in the bone [74], while excessive PPi 
could result in a decrease in mineralization [73, 74]. The correct balance of Pi and 
PPi at extracellular levels [75] plays a dominant role in bone mineralization and 
phosphate homeostasis [69]. Because of its ability to hydrolyzes extracellular PPi to 
Pi, tissue non-specific alkaline phosphatase (TNAP), which is an isoenzyme of 
alkaline phosphatasecould facilitate the deposition of mineral in bone matrix [76].  
Instead of collagen itself which does not induce de novo formation of mineral crystal, 
some specific anionic non-collagenous proteins associating with collagen [77-79] 
stabilize the initial crystal formation and regulate the mineralization process [9]. 
These proteins include osteopontin, osteocalcin, bone sialoprotein, and alkaline 
phosphatase, etc. Determining which proteins are essential for initiating 
mineralization is important, however it can be difficult to decipher the mechanism 
involved in biologic mineralization [9]. 
 
2.3 OSTEOPOROSIS AND THE ALTERATION OF MINERALIZATION 
IN BONE DISEASE  
2.3.1 Osteoporosis 
Alteration of the interrelations between the biological and chemical processes of 
biomineralization may cause some bone diseases, such as osteoporosis, osteopetrosis, 
and osteogenesis imperfect [68]. 
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Osteoporosis (OP) is a very common chronic skeletal disorder leading to increased 
risk of bone fractures characterized by reduced bone mass and density and altered 
trabecular micro-architecture [13]. Bone fractures are the most common and 
dangerous problem of osteoporosis and can occur in almost all bones. Low bone 
density in osteoporosis may result from the imbalance of bone remodeling, meaning 
bone resorption exceeds bone formation [14, 15]. The mechanisms that cause the 
microarchitectural changes in osteoporosis are not clear but may include increased 
bone turnover and microfractures [14].  
There are two types of osteoporosis: primary osteoporosis, which can present in  
postmenopausal woman and secondary osteoporosis, which is related to chronic 
predisposed medical problems or disease or long-term use of medicines that induce 
bone loss [80, 81]. Primary osteoporosis usually occurs in postmenopausal women or 
younger women with an estrogen deficiency after ophorectomia. Postmenopausal 
osteoporosis is commonly related to an increase of unbalanced bone remodelling. 
Secondary osteroporosis usually occurs in men and women older than 75 years of 
age. It can also occur in younger people and is caused by a variety of diseases or 
through the chronic use of certain medications such as steroids [17]. Using 
comparisons with controlled populations, studies have reported both a lower and 
higher heterogeneity in the mineralization in cortical and trabecular bone from 
postmenopausal osteoporotic women [82]. However, the study of mineralization in 
postmenopausal osteoporotic women with hip fractures has shown conflicting 
results. Compared to unfractured controls, postmenopausal women who suffered a 
hip fracture have been linked to either higher [83] or lower bone mineral density 
(BMD) [84]. These discrepancies might be associated with the fact that the 
mechanisms resulting in the loss of bone mass may differ from one patient to another 
(high or low remodelling, premenopausal bone morphology, degree of imbalance 
between resorption and formation, kinetic of the mineral maturation) [19]. However, 
despite the fact that a decrease in mean BMD is well documented in postmenopausal 
osteoporotic women, the association between the risks of fragility fracture with a 
particular mineralization pattern (mean and distribution) remains unclear [19].  
Information detailing the 3D microstructure of the common fracture sites (femoral 
neck, vertebra and distal radius) related to osteoporosis is vital in predicting the 
fracture risk and generating a rich understanding of osteoporosis pathogenesis. 
Increased fragility of femoral neck in osteoporosis is a result of low trabecular bone 
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density and high porosity in the cortical bone. Low BMD of the vertebra is 
associated with increased spine fractures. Vertebral strength is generally maintained 
by trabecular bone -which is heterogeneous in microstructure- where the central 
region has a lower bone volume in comparison to the anterior and superior regions. 
Significant variations in porosity in cortical bone of distal radius is a major factor 
that can affect the strength of distal radius [85]. 
At tissue level, osteoporosis is characterized with low BMD which is associated with 
the microarchitectural deterioration of bone [18]. At the crystal level, altered 
distribution of the mineral characteristics has been reported in osteoporotic patients 
with either high or low remodelling [20]. In such cases, dissociation between mineral 
quantity and mineral quality has been suggested, when compared to normal bone. 
Indeed, the index of mineralization was lower in trabecular bone in osteoporotic 
patients, while the maturity of both mineral and organic matrix was higher than that 
in the control [86]. This change in the correlations between the indexes of the age of 
mineral components and the mineral amount could be one of the causes of bone 
fragility. Multiple studies of bone collagen from human postmenopausal osteoporosis 
and in ovariectomized (Ovx) models have shown that the concentration of 
enzymatically derived crosslinks is greatly reduced when compared with the controls 
[21, 22]. Research in osteoporotic hip fractures in humans and in Ovx monkeys has 
shown that both collagen crosslinking and the overall degree of mineralization of 
bone are different from that of normal bones [21, 22, 87]. This is consistent with 
many other studies showing decreased mineralization in osteoporosis [88]. Collagen 
crosslinks are known to play a role in stabilizing collagen fibril structure and this 
collagen structure acts as a template for mineralization [89]. Therefore, the normal 
mineralization might be interrupted by altered crosslinking of collagen in 
postmenopausal osteoporosis [90]. 
The strength of the collagen network is determined by its connectivity, which is 
controlled by the molecular weight or chain length between crosslinks, 
fragmentation/degradation, and total crosslinking content. The relationships between 
the collagen fibril structure and the subsequent mineralization of the fibril templates 
in postmenopausal osteoporosis remain unclear and require further studies.  
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2.3.2 Alteration of Mineralization in Osteoporosis 
The size of the mineral crystals can be altered by either extrinsic or intrinsic factors, 
such as, the properties of the organic matrix, the distribution of noncollagenous 
proteins involved in the formation and growth of the crystals, environment, diet, 
aging, bone remodeling rate, pathologies, and medications [91]. The effects of 
crystals size on the mechanical properties of bone have not been directly investigated 
in human bone. However, it is known that larger crystals can lead to an increase in 
brittleness and smaller crystals can lead to an increase in ductility. Abnormally 
distributed crystal size has been identified in pathological bone. It is generally 
considered that an “optimal” size and heterogeneity can determine a best strength of 
bone [19, 91]. 
Intermittent treatment with the parathyroid hormone (PTH) is currently the only 
anabolic therapy authorized in the management of postmenopausal osteoporosis. 
Using histomorphometry analysis, an increase in both modelling and remodeling 
activities has been reported in PTH treatment [92, 93]. Accordingly, with this effect 
on bone formation (either modeling or remodeling-related), a decrease in mean BMD 
and an increase in its heterogeneity have been shown at the tissue level [94]. These 
results are supported by the findings that mineral/matrix ratio, mineral maturity and 
organic matrix maturity assessed by FTIRI are significantly lower in patients treated 
with PTH when compared to a placebo in a paired biopsy study [19, 95].  
Research has also indicated that the newly formed bone mineral may be different in 
crystallinity from the mature bone in osteoporosis [86]. Certain elements deposited in 
old bone could be less than newly formed bone even after long-term therapy [96]. 
Under these circumstances, the measurement involving newly formed and old bone 
is worth discussion. 
 
2.4 THE STRUCTURE AND ROLE OF COLLAGEN IN 
MINERALIZATION 
2.4.1 The Role of Collagen in Bone 
As the main building component of extracellular matrix, collagen fibrils play a vital 
role in influencing cell activities, preserving tissue integrity and providing the 
foundation for mechanical properties [97]. In the skeleton bone, the major structural 
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protein is collagen, predominantly type I collagen, which mainly supports 
mechanical functions while providing tensile strength [98]. Even though collagen 
may not directly stimulate mineral deposition in bone matrix, it acts as a 
mineralization template to support initially deposited minerals. Collagen also allows 
for the arrangement of crystal growth by providing the correct framework and 
orientation for the propagation of mineralization [11]. The organization of nano-sized 
platelet-shaped mineral crystallites in bone tissue is determined by the structural 
properties of the organic matrix [1]. Neighbouring collagen molecules generate a 
pattern of gap and overlap regions within the fibrils (Figure 4). Collagen fibres, 
which are created by bundles of hundreds of fibrils, form the structural framework of 
bone. The triple-helix collagen molecule is the smallest unit of the organic 
component in bone [99]. 
Mineral is brittle and stiff while collagen is ductile and soft, and the outstanding 
mechanical properties of mineralized matrix could only be provided by an ideal 
combination of mineral and collagen composition [100]. The mineral to collagen 
ratio differs among species and among types of bones in one animal. The mineral to 
collagen ratio also determines the mechanical properties, to be specific, the 
toughness, stiffness and strength of bone. The bone will be stronger if this ratio is 
higher, but it will also increase the fragileness of bone [68]. 
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2.4.2 The Structure of Type I Collagen 
The synthesis of collagen begins as a polypeptide chain of amino acids which takes 
on a left-handed helical configuration (the α-chain) [101]. Three α-chains (two α 1 
and one α 2 in the case of type I collagen) then counter-wind into a heterotrimeric 
right- handed triple helix (Figure 4). The circular Gly-X-Y triplets (the usual X and 
Y residues are proline and hydroxyproline) exist in each α-helice [97]. Non-helical 
propeptide ends are enzymatically cleaved and the resulting tropocollagen molecules 
assemble into a parallel/staggered twist to form a three- dimensional collagen fibril 
[102] - the primary structural building block of many tissues. The enzyme lysyl 
oxidase then catalyzes the conversion of amino groups of specific lysine or 
hydroxylysine residues to reactive aldehydes which later form stabilizing covalent 
crosslinks [103]. Within a fibril, a reduplicative gap/overlap pattern is formed by 
collagen molecules arrayed in a parallel staggered manner, resulting in the observed 
D-spacing [104]. Due to space between the ends of the tropocollagen molecules and 
Figure 4 The structure of collagen fibre at different levels. 
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an offset from row to row, fibrils have a characteristic oscillating topographical 
feature known as the D-periodicity or D-spacing [97]. The next level of collagen 
hierarchy within the extracellular matrix (ECM) is the organization of fibrils into 
bundles, which is on the scale of micrometer to millimeter. A bundle could be 
qualitatively described as a flock of parallel associated fibrils (the association is due 
to the inter fibrillar cross-links among them) [105]. In bone, it is a lamella sheet of 
parallel collagen fibrils. The twisted plywood structure of bone is constituted by 
collagen fibril lamellaes; and the fibril angles differ among different lamella sheets. 
[106, 107]. 
 
2.5 TRACE ELEMENTS IN BONE METABOLISM 
It is assumed that calcium deficiency or critical calcium intake should play an 
essential role in underlying osteoporosis and in the increased risk of fracture, as 
calcium is the fundamental element of bone. However, compared with low calcium 
intake countries, such as India and Thailand, the countries with high calcium intake 
have a higher incidence of osteoporosis and hip fractures [17], which indicates that 
these diseases may be related to dietary components other than calcium [17]. A brief 
list of the functions of trace elements in bone metabolism is showed in Table.1. 
The composition of the mineral crystals (which consist the main inorganic 
component of bone) is considered to be hydroxyapatite, the formula of which is 
Ca10(PO4)6(OH)2; and each chemical component of it is proved to be capable of 
being replaced with other competitive ions in the surrounding matrix in vivo [23]. As 
a result, calcium ions can be substituted by bivalent metal ions, like magnesium, 
strontium, barium, zinc, nickel, manganese, cobalt and lead ions, while the trivalent 
metals such as aluminium which could not substitute calcium are only present at 
crystal surfaces. The trivalent phosphate anions can be exchanged with 
pyrophosphate or bisphosphonates in the external layers of bone when the certain 
surrounding is rich in these compounds. Fluoride and bromide can replace the 
univalent hydroxyl moiety [24]. 
Previous investigations of the composition of trace elements in human cortical bone 
and beef tendons have resulted in researchers documenting regularity in the 
appearance of certain trace metals, namely Cu, Fe and Zn [108, 109]. This suggests 
that these metals (and possibly other ions) are incorporated structurally into the 
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collagenous matrices of calcified tissues. Non-metal trace element, e.g. fluoride (F) 
has also been found to be physio-chemically linked with the bone mineral matrix 
[110]. In vitro fluoridation of bone can lead to the conversion of carbonated 
hydroxylapatite to carbonated fluorapatite, and produce changes to crystallinity as 
well as the mechanical properties [111]. It is, therefore, thought that biological trace 
elements are indispensable in maintaining the normal physical properties of hard 
tissues. 
Previous research has shown that osteoporosis and aging are connected with 
increased content of magnesium and decreased contents of strontium, fluoride, 
boron, acid phosphate, and carbonate [25]. The levels of skeletal zinc in osteoporosis 
patients have been reported lower than normal individuals [112]. For the treatment of 
osteoporosis, strontium and fluorine are two of the various elements deserving 
special attention. Research over the last decade has shown that the administrations of 
a certain daily low dose of slow release fluoride in medications can increase the bone 
density in trabecular bone [113, 114]. Fluoride salts can increase the functions of 
osteoblasts without having a significant impact on bone resorption and consequently, 
can stimulate bone formation in vivo [115]. Fluoride therapy increases the length and 
content of mineral crystal and decreases crystal width. A positive correlation 
between decreased crystal width and the decreasing ability of tissue to withstand load 
has been identified which may result in an increased risk of fracture [25]. However, 
it should be noted that higher doses of fluoride have potential toxicity. Doses that 
exceed the recommended therapeutic dosage can lead to poor quality and the 
weakening of mechanical properties of bone tissues [17]. Fluoride also appears to 
decrease the availability of calcium in the human body, therefore calcium 
supplementation is considered essential under these condition [116]. Osteoporosis 
treatment using several of the bisphosphonates has been reported to either have no 
effect or to slightly increase crystal width [117]. Research using monkeys and 
rodents has shown that strontium salts, including strontium ranelate, can inhibit bone 
resorption [118]. This effect on bone resorption is probably a result of the direct 
influence strontium has on osteoclasts. Strontium can decrease the size of bone 
mineral crystal while strontium ralenate increases BMD and mineral distribution 
[119, 120]. Chemically strontium is very similar to calcium (which can be substituted 
by the former), however, further research is required to understand the role of 
strontium in bone metabolism and bone disorders [121].  
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Table 1 The functions of trace elements in bone metabolism [124-129] 
Element Function  
Mg  Essential – helps regulate calcium transport, play a role in the 
mineral metabolism of both soft and hard tissues 
Zn Essential – component of many enzymes involved in transcription, 
translation, and nucleic acid synthesis 
Cu  Essential – essential for bone metabolism, e.g. for lysine oxidation 
Mn  Essential – e.g. for glycosyl transferase 
Se  Essential – important role inbone formation and homeostasis 
Bo  Essential – reduces Ca excretion 
Sr  Essential  – influence bone turnover, enhance osteogenic 
differentiation and stabilize bone structure 
F  Essential – stimulates bone formation, enhances the stability of 
apatite lattice 
Al  Toxic – reduces osteoblast activity 
Cd  Toxic – affects calcium metabolism 
Pb  Toxic – accumulates in bone 
Si Essential – positively correlated with bone homeostasis and 
regeneration 
Cr enhance the activity of insulin and provide higher level of 
steadiness to collagen  
K reduce bone resorption 
 
 
2.6 METHODS TO INVESTIGATE MINERALIZATION IN BONE 
Various techniques can be utilised to test the degree of mineralization of bone or 
bone mineral density distribution (BMDD). Laser ablation inductively coupled 
plasma mass spectrometry (LA-ICP-MS) is a recently developed analytical tool that 
can explore the trace element distribution of both beneficial or toxic metals and non-
metals in biological tissues, ranging from plants [122] to animal tissues [123]. [124-
129]. 
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In the past, quantitative microradiography (qMR) was first used to illustrate and then 
quantify the mean BMD and the heterogeneity of mineralization at the tissue level 
[130-132].  Quantitative backscattered electron imaging (qBEI) [19, 88, 133], 
synchrotron radiation microcomputed tomography [134, 135], fourier transform 
infrared imaging (FTIRI) or microspectroscopy (FTIRM), and Raman spectroscopy 
were later suggested [20, 24, 88, 136, 137].  
Vibrational spectroscopic methods such as infrared and Raman techniques could 
generate information on the chemical environment and structural detail of the 
mineral and collagen present in bone. Determined by the position of atomic bonds in 
molecules located within bone, the vibrations from these atoms (detected by infrared 
and Raman techniques) can be used for the quantitative analysis of mineral 
composition and its content [27, 28].  
The mineral structure could be investigated by applying qBEI which is capable of 
revealing the BMDD [138]. Furthermore, to investigate the shape and the properties 
of crystals, such as crystallinity, length, width, and lattice parameters techniques such 
as X-ray and electron diffractions could be employed. Small-angle X-ray Scattering 
(SAXS) could be used to characterise mineral particle size and alignment in bone 
along with wide-angle X-ray scattering (WAXS) and high-resolution transmission 
electronic microscopy [19].  
By combining qBEI with other scanning techniques, such as the methods mentioned 
above, corresponding information on the bone matrix at identical locations could be 
obtained. Furthermore, bone mineral content in biopsied tissue could be mapped and 
the quantity could be measured within a localized region of the samples [9, 88, 139]. 
To determine the presence of bone mineral, X-ray diffraction (XRD) is the most 
reliable method to use. The changes in particle sizes detected by SAXS could be in 
the range of 2–25 nm, whereas the changes detected by XRD could be narrowed 
down to less than 1 nm [9]. Both XRD and electron diffraction techniques have 
proven useful for characterizing mineral associated with matrices and matrix vesicles 
developed in culture [140]. However, as to the amount of mineral, neither X-ray 
diffraction nor electron diffraction is able to quantify. It is necessary that this kind of 
examination utilise quantitative analysis methods instead. Energy-dispersive X-ray 
analysis (EDX) can generate the information necessary to determine the chemical 
composition of the specimen surface. Combined with scanning electron microscopes 
(SEM), EDX allows researchers to observe the morphology of the mineral deposit 
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and instantaneously measure mineral ratios -such as calcium to phosphate ratios - 
with proper chemical standards [9, 29].  
Using radiographic methods, changes in X-ray attenuation could be revealed when 
minerals are present. These methods include: plain films, peripheral quantitative 
computed tomography (pQCT), micro computed tomography (micro-CT)  and dual 
energy X-ray absorptiometry (DEXA) [9]. 
Quantitative computed tomography (QCT) which is capable of detecting bone loss 
and its high-resolution peripheral counterpart (HR-pQCT) make in vivo 
measurement for both trabecular and cortical density possible [141]. Moreover, HR-
pQCT scanners now allow in vivo imaging of 3D trabecular morphology at 
peripheral sites such as the distal radius [9, 142, 143].  
Using transmission electron microscopy (TEM), the shape and size of the collagen 
fibers and mineral crystals could be shown. Furthermore, selected area electron 
diffraction (SAED) which is similar to X-ray diffraction could generate characteristic 
patterns which are then utilized to measure the composition and crystallite size of 
mineral crystals. As is seen in physiological conditions, mineral crystals deposit 
along the c-axis parallel to the collagen fibres, however, mineral deposits may not 
always appear that way under certain pathological situations. Such appearances could 
potentially be observed with TEM [30].  
Atomic force microscopy (AFM) allows for the investigation of the superficial 
structure of various materials and can be applied to image collagen fibres and also 
individual bone crystals [144, 145]. This high-resolution microscopy technique is 
able to picture individual crystals by relying on a probe that makes contact with a 
specimans surface [9].  
The distribution of acid phosphate and the topography of mineral crystals could be 
shown by using magnetic resonance imaging (MRI) and nuclear magnetic resonance 
(NMR) techniques. Solid-state NMR spectroscopy has been used for a long time for 
studies of
 1 
H, 
13 
C, and 
31 
P of bone mineral and calcium phosphates [146]. Magic 
angle spinning (MAS) and MAS coupled with cross polarization (CP-MAS) have 
been used in developing bone and disease models to identify initial mineral and 
matrix composition [147-149].  
Further to its use with non-mineralized biological samples LA-ICP-MS has also been 
used for mineralised tissue [150-152] which is of particular interest to present 
research. However, one of the most challenging issues in the application of LA-ICP-
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MS is the lack of internal standards and Certified Reference Materials (SRM). 
Ideally, a suitable internal standard should reflect the in vivo situation in order to 
account for differences in physio-chemical aspects between biological samples and 
calibration standards [150, 153]. Additionally, optimized internal standards should 
possess similar reproducible matrix compositions in order to ensure data obtained in 
different experiments are consistent and comparable [154]. Recently, there have been 
a number of studies using pelletized NIST (National Institute of Standards and 
Technology) SRM 1486 Bone Meal or SRM 1400 Bone Ash as a control material. 
However, both of these two SRMs are expensive and the matrix composition is 
expected to become altered after sintering or boiling. In much of the published data, 
the selection of the internal standard has only been given scant attention especially in 
LA-ICP-MS quantification experiments. 
Measuring changes in calcium or phosphate concentrations in solution is often 
achieved by the use of radiolabeled ions and as a result, mineral can be characterized 
in vitro. The use of histochemical stains to quantify phosphate and calcium increase 
in culture is also a popular method and this is done by extracting the stained culture 
to quantify these values. One of the disadvantages of this histochemical method is 
that these stains are often not specific enough for mineral quantification. For 
instance, von Kossa staining for phosphate can mark phosphate containing matrix 
molecules in the same way, particularly cell membranes [29, 155, 156]. Alizarin 
redcan also stain calcium bound to proteoglycans, which is mainly used to stain 
calcium ion in calcium phosphates [29, 155].  
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Chapter 3: Research Design 
3.1 METHODOLOGY 
3.1.1 Animal samples 
All the samples used for this study were from animals developed for the previous 
project “Effects of osteoporosis on osseointegration in rat maxilla”. The existing 
osteoporosis and sham control rat bone samples were studied in the current project. 
Sprague-Dawley female rats (3 months old, n=48) were used for the osteoporosis 
project after the animal ethics was obtained from the Animal Ethics Committee of 
Fujian Medical University and Griffith University. One group of rats underwent 
sham operation (Sham, n=24) and a bilateral ovarictomy (Ovx, n=24) was performed 
on another groups of rats, as described previously [157, 158]. Ligatures were placed 
at the end of the fallopian tube to exteriorize ovaries in rats of the Ovx group while 
fat tissues of the same size were removed near the ovaries in rats of the Sham group. 
Screw-shaped micro-rough surface-modified implants (2 mm in diameter × 3 mm 
long, Ra = 1.55 μm) were obtained from Southern Dental Implants (Irene, South 
Africa). Implant placement was performed under general anesthesia. Briefly, one 
maxillary first molar was extracted from each animal followed by immediate 
insertion of the implant into the freshly extracted socket. At 8, 12, 16, and 20 weeks 
after ovariectomy or sham operation, six rats from each group were sacrificed. Tibia 
and maxilla were then collected from each animal and fixed in 4% paraformaldehyde 
(PFA, Sigma, Australia) for 24 hours. The specimens were dehydrated in a series of 
graded alcohols and embedded using Technovit 7200 resin (Heraeus Kulzer GmbH, 
Wehrheim, Germany).  
The samples of Sham and Ovx were divided respectively into two groups: new bone 
and old bone. According to previous experiences and relevant literatures [157, 159-
162], the newly formed bone is defined within 40µm distance from the implant 
surface after 8 weeks post implant operation as this space is normally filled with 
blood clot after the placement of implant. Therefore, the newly formed bone was set 
as the area 40 µm above the interface of the bone and implant (Figure 5 & 6 in Result 
Chapter). 
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3.2  MEASUREMENT OF BONE MINERAL COMPOSITION 
In order to further observe the changes of mineralised tissues caused by osteoporosis, 
the following instruments were used for this research. The composition of mineral 
was measured by energy-dispersive X-ray spectroscopy (EDS) combined scanning 
electron microscopy (SEM). The distribution of trace elements was measured by 
laser ablation inductively coupled plasma mass spectrometer (LA-ICP-MS). The 
structure of collagen and mineral crystal was observed and investigated by 
transmission electron microscope (TEM) and selected area electron diffraction 
(SAED) patterns. 
 
3.2.1 Scanning Electron Microscope 
Scanning electron microscope (SEM) is a type of electron microscope that generates 
high-resolution images of shapes and shows the chemical composition of a sample 
by scanning it with a focused beam of high-energy electrons. The electrons interact 
with the atoms in the sample and various signals are generated. These signals are 
detected by the detectors in the microscope and provide relevant information about 
the topography and composition of the sample. 
The most important signals produced are secondary electrons (SE), backscattered 
electrons (BSE) and X-rays. SE signal provides topographic contrast containing 
information on the surface of the sample. Images of the surface of the sample are 
produced which can reveal details less than 1 nm in size. BSE gives compositional 
contrast providing information on the composition of the sample. For example, 
heavier elements appear brighter on the image. X-rays are detected by an energy 
dispersive spectrometer (EDS) and are used to measure the composition and quantity 
of elements in samples [163].  
Samples are required to be dry since the chamber of SEM is a vacuum and biological 
samples need to be fixed before observation with SEM. Samples can be coated with 
gold or carbon if they don’t have sufficient electrical conductivity. 
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3.2.2 Energy Dispersive X-ray Spectroscopy 
Energy Dispersive X-ray Spectroscopy (EDS, EDX or XEDS) is a technique that can 
provide information on the chemical composition of a sample. The technique relies 
on an interaction of some source of X-ray excitation and a sample. It allows for the 
identification of particular elements and the relative proportions of a sample. This 
works best for elements with atomic number (Z) >3. It is generally combined with a 
scanning electron microscope (SEM) or a transmission electron microscope (TEM). 
The outputs of EDS analysis normally include a spectrum, map and quantitative 
analysis of the elements. In the spectrum, peaks reveal the elements that have been 
identified in the sample. The map provides an image that shows the distribution and 
concentration of one element within an area of a sample. Different colours indicate 
different element concentrations. Quantitative analysis produces a table of 
concentrations of all the major and minor elements (weight percentages) in the 
sample [164]. 
Accuracy of EDS analysis can be affected by various factors including the nature of 
the sample. The X-ray (generated by the interaction of the atoms in the sample and 
the beam) can be emitted in any direction and as a result some the sample may not be 
detected. The reduced accuracy could be due to an inhomogeneous and rough 
sample. 
There is no special sample preparation needed for qualitative analysis. However, if it 
is a requirement that the sample be imaged in the SEM or TEM then the sample must 
be flat and polished for quantitative analysis in the SEM [164]. 
 
3.2.3 Sample Preparation  
Eight resin embedded samples (8 weeks) were sequentially grounded with #800 and 
#1500 grit sandpaper and then polished using diamond grains of 2.5 µm in size on 
hard polishing cloths (Struers Tegramin-30 Grinder-Polisher, Denmark). The 
polisher was set on manual mode with a speed of 300 rpm. After polishing, the 
polished surface of each sample was washed with 80% ethanol and distilled water to 
remove the remaining diamond grains. The surfaces of whole maxilla with bone-
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implant blocks were polished and coated with a thin gold layer using vacuum 
evaporation. 
3.2.4 Sample Measurement  
To investigate the mineral composition, the weight percentage of calcium and 
phosphate was measured by SEM-EDS. The maxilla specimens were used to 
evaluate the mineral elements using scanning electron microscopy (SEM) with the 
backscattered electrons as described previously [165]. Using a field emission 
environmental scanning electron microscope (Carl Zeiss SMT GmBH, Oberkochen, 
Germany), the operation was performed in a high vacuum mode at a working 
distance of 10 mm and an accelerating voltage of 10–15 kV. Energy-dispersive X-ray 
spectroscopy (EDS, n=4) was carried out on the same instrument fitted with an 
Oxford Instruments INCA 300 EDS System, Abingdon, Oxfordshire, UK. EDS was 
used to evaluate the elemental composition in bone adjacent to the dental implant. 
Eight to ten sites of interest per specimen were analysed. At least three points inside 
each group in the central areas of the dental implant and near the edges was 
investigated, six points in the newly formed bone surrounding the dental implant and 
six points in bone 1-2 μm from the interface. 
 
3.3 OBSERVATION OF BONE COLLAGEN AND MINERAL CRYSTAL 
3.3.1 Transmission Electron Microscope 
Transmission electron microscopy (TEM) is a type of electron microscope that 
generates 2-dimensional high-resolution and high magnification images by the 
interaction of a beam of electrons transmitted through an ultra-thin specimen.  
A TEM allows visualisation and analysis of samples from microspace (1 micron/1μm 
= 10
-6
m) to nanospace (1 nanometer/nm = 10
-9
m). It uses a focused beam of high 
energy electrons and produces high-resolution and high magnification imaging with 
detailed micro-structural examination. Magnifications of up to 1,000,000x and 
resolution below 1 nm can be achieved. Crystal structures, specimen orientations and 
chemical compositions can also be investigated through a combination of diffraction 
patterns, X-ray and electron-energy analysis [166]. 
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The preparation of TEM samples can be complex and it is a requirement that samples 
be a maximum of hundreds of nanometers thick and be put on a grid [167]. The 
common methods of TEM sample preparation include ultramicrotomy and ion 
milling, etc.  
 
3.3.2 Sample Preparation 
Eight resin embedded samples (8 weeks) were gold coated as described above before 
TEM sample preparation was initiated. Resin in ultrathin sections of 100 nm was 
prepared with Quanta 3D dual-beam focused ion beam microscope (FEI Corporate, 
USA). The gold coated sample was attached to a sample holder and a TEM grid was 
fixed into the grid holder. Both were placed into the chamber of the microscope. A 
protective platinum layer was initially deposited on the selected area of an original 
resin embedded sample. Both sides of the protection layer deposited lamella were 
milled by ion beams and two trenches were dug to mill the lamella with the ion 
beam. The lamella was polished off layer by layer on both sides in order to reach the 
required thickness. The polished section was then cut from the original sample and 
welded to the micro-manipulator. The lamella was transferred to the TEM grid by the 
manipulator and was detached with the manipulator by the ion beam. Finally, the 
section was thinned down using ion beams to a thickness of about 100nm.  
 
3.3.3 Observation of Collagen and Mineral with TEM 
Grids with samples were carbon-coated, and a gold layer was placed on the side to 
serve as a reference. For each sample and bone compartment, five measurements 
from the newly formed bone and five from the old bone were taken. Each grid was 
examined under JEOL 1400 120kV Transmission Electron Microscope (TEM) under 
a HV of 100kV to observe nanostructure of bone.  
 
3.3.4 Selected Area Electron Diffraction 
Selected area electron diffraction is a crystallographic experimental technique that is 
carried out with a TEM. The SAED patterns are used to identify crystal and provide 
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information about its orientation and crystallinity from selected regions of the sample 
from the micron to the ~100nm scale [168]. Using SAED, the areas of interest can 
easily be chosen to obtain the diffraction pattern by inserting the selected area 
aperture into the beam path. Interference patterns are produced in the electron beam 
as it passes through the lattice. A crystal lattice acts as a diffraction grate and these 
patterns can be shown as an image of regular dots or rings [169].  
The nature of crystalline phases in the specimen can be reflected in the appearance of 
the diffraction pattern [170]. The SAED pattern from crystalline shows bright spots. 
The pattern from the polycrystalline phase shows a series of rings which is made up 
of small spots with each spot from an individual crystallite, while the pattern from 
the amorphous matrix has a diffuse ring pattern [171]. In this case, the crystalline 
phase of a sample can be determined as each phase has a characteristic SAED 
pattern. 
 
3.3.5 Observation of Mineral Distribution of Mineral Crystal 
Selected area electron diffraction (SAED) patterns: To investigate the effect of 
Ovx on bone formation, selected area electron diffraction was employed to determine 
the biological apatite distribution. Selected area electron diffraction (SAED) patterns 
were processed with Process Diffraction v4.3.8.B software within the interest zones 
(newly formed or old bone). After the sample was examined in image mode and the 
area of interest was found, the objective aperture is then removed. The intermediate 
aperture passed the image of the selected area. The microscope was switched to 
selected area diffraction mode and the SAED pattern was obtained. 
 
3.4 MEASUREMENT OF TRACE ELEMENTS DISTRIBUTION  
3.4.1 Laser Ablation Inductively Coupled Plasma Mass Spectrometer 
Laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) is a type 
of mass spectrometry that is able to detect metals and several non-metals by ablating 
with a pulsed laser beam. It is especially helpful for analysis of trace elements and 
offers extremely high sensitivity to a wide range of elements. It can perform ultra-
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highly sensitive chemical analysis down to the ppb (parts per billion) level without 
any sample preparation [172].  
LA-ICP-MS allows multipurpose analysis including; bulk analysis, local inclusion 
and defect analysis, depth profiling, and elemental/isotope mapping. The two 
methods that are most commonly used are: 1) bulk analysis with a typical laser spot 
size of 100 ~ 350μm and 2) microanalysis with a laser spot size as small as a few 
microns. Samples can be either conductive or non-conductive and the analysis can be 
achieved in the air without the need of a vacuum system [172]. 
 
3.5 TRACE ELEMENTS MEASUREMENT WITH LA-ICP-MS 
To further investigate the trace elements distribution in Ovx and Sham samples, the 
element distributions in tibia and maxilla embedded in resin were analysed using the 
glass matrix NIST SRM 612 and 610 (National Institute of Standards and 
Technology, Gaithersburg, MD, USA) as external calibrate standards. LA-ICP-MS 
was carried out by quadrupole ICP-MS (Agilent Technologies Inc., Santa Clara, 
California, USA). The unstained samples as resin blocks along with a Si-Al-Ca-Na 
glass as a trace element standard were placed in the laser sample chamber which was 
repeatedly evacuated and back-filled with He to omit a changing gas (air +He) 
composition from the introduction system. ICP-MS operating parameters are 
summarized in Table 2. A glass wafer standard reference material SRM NIST 612 
glass (National Institute of Standard and Technology, Gaithersburg, MD, USA) was 
used as an indicator of counts per ppm. Scans of varying duration were bracketed by 
50 seconds of background (laser-off) data acquisition.  
For LA-ICP-MS, an Agilent 8800 single collector, quadrupole ICP-MS (Agilent 
Technologies Inc., Santa Clara, California, USA) was employed in this work with a 
193 nm wavelength exciter laser and 2-volume Trueline ablation cell from ESI New 
Wave Research (Bozeman, Montana, USA). Parameters such as gas flows and 
repetition rate were optimized for laser ablation analysis. The resin samples and 
NIST standards were secured in the laser sample chamber, which used Helium (He) 
as carrier gas and was repeatedly evacuated and back-filled with He to omit a 
changing gas (air+He) from the introduction system. The laser was set with a modest 
energy output generating a fluence of 3.0 J/cm
2
, and a pulse rate of 10 Hz. A masked 
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rectangular beam of 15 × 150 microns was moved parallel to the short dimension at 5 
microns/second to create a track approximately 750 microns long and 15 microns 
deep in the tissues. The time to cycle through the 9 selected isotopes was 0.12 s. 
Scans of varying duration were bracketed by 50 seconds of background (laser-off) 
data acquisition. Data were analysed and displayed using IOLITE [173]. 
After the prepared samples were secured in the ablation chamber, the whole system 
was purged with He carrier gas at 0.5 L min
-1
 for 3 hrs prior to each measurement to 
minimise the 13C background noises. In addition, a background signal was collected 
during the first 30 s of analysis. 
 
Table 2 ICP-MS operating conditions 
 
Parameters Values  
RF power  1550W  
Sampling depth  5mm  
Sample (argon) flow  0.85 L/min  
Isotopes measured  12C,13C,23Na,29Si,31P,39K,43Ca,59Co  
Mass cycle time  0.12 s total, seep time on 59Co=0.02s  
 
3.6 STATISTICAL ANALYSIS  
Mean values ± standard deviations (SD) were presented for the data of each 
specimen. A test was conducted and the data accord with normal distribution. 
Statistical analysis was performed using one-way ANOVA followed with post-hoc 
Tukey HSD (Honest Significant Differences) Test. A difference was considered 
significant when p<0.05. 
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Chapter 4: Results 
4.1 RESULTS OF SEM OBSERVATION AND MEASUREMENT 
4.1.1 Backscattered Electron Imaging of Bone 
The surface condition of bones was observed by backscattered micrographs. From 
the image, the grey part represents the mineralized tissues and the cell lacuna. 
Cavities of vessel are shown as black. The view of the implant interface 
demonstrated bone mineral which was adjacent to the titanium implant was shown as 
bright and relatively lighter grey. This backscattered electron micrograph image 
shows the method used in this thesis to define the newly formed bone area. The area 
between the yellow dot line and the implant was referred to as newly formed bone 
according to the method described in the Methodology chapter (Fig. 5 & 6). The old 
bone area was identified as being located at the far side from the implant interface.  
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Figure 5 Method used to distinguish the newly formed bone and old bone. New 
bone was identified as the newly-formed mineral tissue which was between the 
yellow dot line and implant.  
20 µm 
Implant 
New 
Bone 
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Figure 6 Area of interest of newly formed bone and old bone. New bone was identified 
as Figure 5 and old bone was identified as the area at left of the red line. 
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4.1.2 Mineralization Density Analyses 
Mineralization density marker of Ca/P ratio was detected by using the EDS 
technique for new bone and old bone in both the Sham and Ovx groups. Predominant 
concentrations of calcium and phosphate were observed in the bone surface and were 
shown in EDS spectra (Fig. 7a, b, c and d). Samples featured distinct characteristic 
peaks at 3.7 keV for Ca and 2.0 keV for P, and consistent Kα emission lines. 
Weight percentage of detected elements was also generated by EDS. Results on the 
bar graph show that Ca/P ratio in Ovx groups had no significant difference when 
compared to that of Sham groups (Fig. 7e). 
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Figure 7 (a-d) Element compositions as representative spectra from energy 
dispersive X-ray (EDS) analysis. (e) Summary of Ca/P ratio of the samples measured 
by EDS. 
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4.2 RESULTS OF TEM OBSERVATION 
4.2.1 Effect of Ovx on bone collagen and apatite crystals  
TEM micrographs were performed to reveal the longitudinally-sectioned mineralized 
collagen fibrils alignment. The TEM results showed regular alignment of fibrils with 
the periodic banding characteristic of collagen fibrils in all the groups (Fig.8a, b, d, e, 
g, h, j, and k).  
In addition, SAED patterns were also investigated to demonstrate the orientation of 
hydroxyapatite (HA) crystals according to the pattern of the (002) plane which 
appeared as arc plane (Fig.8e, f, i, l). The inner ring (002) which was observed  as 
being inconsistent in all groups represented the orientation of crystals and was 
identified by the connecting line of the mid-point of the rings. This orientation 
showed by SAED patterns indicated that the c-axis of mineral crystals were along the 
long axis of the collagen fibrils in all groups. However, from the SAED patterns of 
osteoporotic bones, even though they show a similar orientation with collagen fibrils, 
the spots which do not shape a smooth ring indicate mono crystallite of mineral in 
osteoporotic bones. 
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Figure 8 TEM micrographs of longitudinally-sectioned mineralized collagen fibrils and selected 
area electron diffraction (SAED) patterns. Fig. 8a, d, g, j are the images obtained by TEM, Fig.8b, 
e, h and k are the higher magnification images. Fig.8c, f, i, l are SAED patterns and the blue 
arrows represent the orientation of the mineral crystals. 
002 
002 
002 
002 
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4.3 RESULTS OF LA-ICP-MS MEASUREMENT 
4.3.1 Elements distribution assessed by LA-ICP-MS 
The distribution of elements was measured by laser ablation inductively coupled 
plasma mass spectrometry (LA-ICP-MS). Ca/P ratio was calculated using LA-ICP-
MS to gain more accurate results besides the previous EDS measurement.  
 
4.3.2 Ca/P ratio of tibia and maxilla  
To further investigate the effect of Ovx on tibia and maxilla, LA-ICP-MS results 
were analysed to show the different concentrations of calcium and phosphorate in 
osteoporotic and sham-operated rats. Generally, ovariectomy mainly decreased the 
Ca/P ratio values in tibia and there was no significant difference in maxilla over time 
(Figure 9). No difference was detected between new bone and old bone in maxilla for 
the Ca/P ratio in both Sham and Ovx groups (Figure 10). 
  
 
  
  
 
Figure 9 The Ca/P ratio values (normalised against matrix-matched reference 
materials) in tibia and maxilla increased after ovariectomy   at different time points 
post-surgery 
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4.3.3 The effect of Ovx on the average concentrations of atomic minerals in tibia 
and maxilla at defined time points 
As seen in Table 3, the average concentrations of 
25
Mg, 
28
Si, 
39
K, 
47
Ti, 
56
Fe, 
59
Co, 
66
Zn, 
77
Se, 
88
Sr, 
137
Ba, and 
208
Pb were analysed for both tibia and maxilla at pre-
defined time points by LA-ICP-MS. In general, Ovx rats had higher concentrations 
of all the evaluated elements in tibia samples than that of maxilla samples at each 
time point. For tibia, concentrations of 
28
Si, 
39
K, 
77
Se, and 
208
Pb were detected higher 
in osteoporotic bones than in normal bones as shown in Table 3. Furthermore, higher 
concentrations of 
28
Si, 
77
Se, 
88
Sr, 
137
Ba, and 
208
Pb were detected in osteoporotic 
maxillary bones than in normal bones as demonstrated in Table 3. It was noted that 
Ovx resulted in higher concentrations of 
28
Si, 
77
Se, and 
208
Pb in both tibia and 
maxilla compared with the Sham group over time.  
 
  
Figure 10 Summary of Ca/P ratio of the new bone and old bone in 
maxilla measured by LA-ICP-MS. 
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Table 3 The effect of Ovx on the average concentrations of atomic minerals in tibia 
and maxilla over time 
Element                             Concentrations (ppm)                       Time points 
 NIST 
610 
Tibia Maxilla  
 Ovx (n=6) Sham (n=6) Ovx (n=6) Sham (n=6)  
 
Mg 24 
 
464.9±5.36 
 
283±23.53 
 
1335±199.42 
 
166.57±3.10 
 
159.33±2.19 
 
8 weeks 
  2513±91.19 1697.5±210.78 174.37±5.69 228.2±5.36 12weeks 
  2810±310 1115±167.63 164.5±9.19 174.86±8.14 16 weeks 
  1794.5±255.2 1310±113.58 540±78.1 358.4±36.12 20 weeks 
Si 28 326975±1027 1410±200.74 355.67±23.54 2.35±0.31 5.22±0.41 8 weeks 
  1283.3±137.8 473.33±45.83 8.9±1.04 2.77±0.25 12weeks 
  1545±164.15 440±24.13 21.29±3.54 2.34±0.31 16 weeks 
  2670±188.91 430±42.43 45.15±5.28 2.83±0.29 20 weeks 
K 39 487±17.11 62.09±5.21 96.25±17.31 9.48±1.08 5.91±0.56 8 weeks 
  968±109.03 126.33±15.45 26.14±2.52 34.13±4.07 12weeks 
  272.33±25.65 170.25±20.33 35.23±5.37 25.95±2.74 16 weeks 
  622±50.91 237.5±17.61 55.5±7.06 42.2±5.21 20 weeks 
Ti 47 433.9±1.53 1.67±0.18 0.77±0.11 0.22±0.02 0.30±0.01 8 weeks 
  2.37±0.31 0.62±0.05 0.39±0.03 0.31±0.04 12weeks 
  3.53±0.56 5.01±0.45 0.29±0.001 0.36±0.02 16 weeks 
  2.1±0.32 5.3±0.51 0.45±0.05 0.41±0.05 20 weeks 
Fe 56 456.4±8.13 31.05±5.01 424.33±10.26 1.86±0.23 1.81±0.25 8 weeks 
  1594±152 464±26.9 2.03±0.15 2.46±0.31 12weeks 
  1554±152.1 623.33±90.73 2.8±0.63 2.78±0.42 16 weeks 
  839.5±55.9 1015±91.9 3.86±0.35 3.81±0.34 20 weeks 
Co 59 405.1±6.12 0.007±0.0008 0.042±0.005 0.0007±0.0001 0.0018±0.00035 8 weeks 
  0.068±0.0016 0.022±0.003 0.0042±0.0001 0.0015±0.00016 12weeks 
  0.064±0.0039 0.034±0.004 0.0019±0.0002 0.029±0.0024 16 weeks 
  0.028±0.0037 0.048±0.006 0.0088±0.0012 0.031±0.0043 20 weeks 
Zn 66 456±5.56 31.4±0.71 152.2±20.61 26.92±4.41 8.96±1.03 8 weeks 
  378.25±51.02 173.25±31.01 22.68±2.98 35.1±5.76 12weeks 
  722±37.61 238±36.13 26.81±4.09 33.65±1.93 16 weeks 
  246±37.98 251.67±36.16 42.75±6.25 62.21±7.35 20 weeks 
Se 77 108.8±1.02 0.1026±0.013 0.367±0.028 0.0037±0.00051 0.0025±0.00015 8 weeks 
  3.8±0.516 0.93±0.152 0.0049±0.00071 0.0043±0.00075 12weeks 
  2.8±0.17 0.7±0.068 0.5986±0.851 0.145±0.0135 16 weeks 
  0.71±0.075 0.85±0.121 0.2825±0.0335 0.1542±0.0125 20 weeks 
Sr 88 515.95±5.1 2.475±0.4 2.57±0.19 3.63±0.46 2.59±0.35 8 weeks 
  5.625±0.41 13.43±0.97 4.04±0.27 2.41±0.25 12weeks 
  12.58±0.75 3.34±0.28 4.21±0.65 3.31±0.24 16 weeks 
  8.45±1.51 5.39±0.23 3.76±0.51 3.46±0.45 20 weeks 
Ba 137 435.05±7.95 0.625±0.09 0.68±0.13 0.525±0.048 0.211±0.032 8 weeks 
  1.53±0.159 3.17±0.57 0.952±0.11 0.875±0.102 12weeks 
  7.62±0.73 3.88±0.48 1.02±0.101 0.737±0.11 16 weeks 
  3.48±0.329 3.18±0.47 0.94±0.13 0.85±0.15 20 weeks 
Pb 208 426.17±4.97 2.89±0.298 1.66±0.21 0.18±0.0157 0.012±0.00729 8 weeks 
  3.617±0.349 1.46±0.05 0.291±0.0028 0.129±0.0255 12weeks 
  8.95±0.89 3.55±0.49 0.397±0.026 0.273±0.013 16 weeks 
  12.95±0.49 7.533±1.059 2.11±0.305 0.3654±0.0512 20 weeks 
Mg: magnesium; K: potassium; Ti: titanium; Fe: iron; Si: silicon; Co: cobalt; Zn: 
zinc; Ba: batrium; Sr: strontium; Pb: lead; Se: selenium 
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4.3.4 The concentrations of atomic minerals, 59Co and 208Pb, in tibia and maxilla 
The average concentrations of 
59
Co and 
208
Pb in tibia and maxilla were evaluated in 
this study. The accumulated concentrations of 
208
Pb were found to be significantly 
higher in both tibia and maxilla from the Ovx group than the Sham group in a time-
dependent manner (Fig. 11a, b). More importantly, there was a higher concentration 
of 
208
Pb in tibia than in maxilla at all evaluated time points (Fig. 11c).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As shown in Figure 12, higher concentrations of 
59
Co were detected in tibial bones 
from the Ovx rats at both 12 and 16 weeks compared with the Sham-operated rats 
Figure 11 Ovx increased the average concentrations of 
208
Pb (normalised against 
matrix-matched reference materials) for both tibia (a) and maxilla (b) at all time-points 
post-surgery when compared to the Sham group. (c) Tibial trabecular bone 
accumulated more lead ions compared to maxillary cortical bone. *: Significant 
difference (p<0.05) between Ovx-Tibia and the other groups. 
(c) 
(a) (b) 
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(Fig. 12a). Meanwhile, there was a significantly higher concentration of 
59
Co found 
in maxilla at both 16 and 20 weeks from the Ovx group compared to the Sham group 
(Fig. 12b). Figure 12c demonstrates that Ovx led to a higher concentration of 
59
Co in 
tibia than in maxilla at all time-points.  
 
  
Figure 12 The average concentrations of 
59
Co in tibia (a) and maxilla (b) at different 
time points after the surgery. (a, b)At 12 week, there was a higher concentration of 
cobalt found in both tibia and maxilla in Ovx rats when compared to the Sham-
operated rats. (c) Comparison of 
59
Co concentrations in tibia and maxilla in a time-
dependent after the surgery. 
 
(b) (a) 
(c) 
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4.3.5 The effect of Ovx on the concentrations of 66Zn, 88Sr and 137Ba in tibia and 
maxilla 
The result of LA-ICP-MS demonstrated that ovariectomy resulted in more 
66
Zn in 
tibia at 12 and 16 weeks compared with the Sham operation (Fig. 13a). There was a 
higher concentration of 
66
Zn detected in maxilla from the Ovx group at 8 weeks, 
while the maxilla from the Sham group showed more 
66
Zn at other time points (Fig. 
13b). In general, tibia samples presented with a higher concentration of 
66
Zn 
compared to the maxilla samples at all time-points (Fig. 13c). 
 
 
 
 
 
 
 
 
Figure 13. The average concentrations of 
66
Zn in both tibia (a) and maxilla (b) after 
normalised against matrix-matched reference materials at different time points post-surgery. 
(a) Ovx resulted in more Zn in tibia at 12 and 16 weeks. (b) There was a higher concentration 
of Zn detected in maxilla from the Ovx rats at 8 weeks, while the Sham group showed more Zn 
in the other time points. (c) Obviously, tibia samples showed a higher concentration of Zn 
compared to the maxilla samples. 
(c) 
(b) (a) 
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It was noted that Ovx increased the average concentrations of 
88
Sr in tibia at 16 and 
20 weeks after the surgery compared to the Sham group (Fig. 14a). The 
concentration of 
88
Sr was found higher in maxillary bones from the Ovx-operated 
rats at all time-points compared with the Sham group (Fig. 14b). Furthermore, there 
was a higher concentration of 
88
Sr detected in the maxilla from the Ovx group 
compared to the Sham group at all different time points post-surgery (Fig. 14c).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14 Ovx increased the average concentrations of 
88
Sr in tibia at 16 and 20 weeks 
after the surgery (a). The concentration of 
88
Sr was found higher in Ovx-operated 
maxilla at all time-points (b). A generally higher concentration of 
88
Sr was detected in 
the maxilla from the Ovx group compared to the Sham group at all time-points post-
surgery (c). 
(c) 
(a) (b) 
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The effect of Ovx on the average concentration of 
137
Ba was assessed for both tibia 
(Fig. 15a) and maxilla (Fig. 15b) at different time points post-surgery. It was noted 
that Ovx increased the concentration of 
137
Ba in maxilla at all time-points compared 
with the Sham group (Fig. 15b). However, there was a generally higher concentration 
of 
137
Ba detected in tibia than in maxilla at all evaluated time-points (Fig. 15c). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 15 The effect of Ovx on the average concentration of 
137
Ba in both tibia (a) 
and maxilla (b) at different time points post-surgery. (b) Ovx increased the 
concentration of Ba in maxilla at all time-points. (c) A generally higher 
concentration of Ba was detected in tibia than in maxilla. 
(b) 
(c) 
(a) 
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Average 
56
Fe cts Average 
66
Zn cts Average 
88
Sr cts Average 
138
Ba cts Average 
208
Pb cts
in selected in selected in selected in selected in selected
integration  integration  integration  integration  integration
NIST 610 Glass 4444±57 554±10 4426±32 1169±4 4749±28
Sham NB 1695±350 470±81 716±154 9.81±2.16 6.53±1.80
Sham OB 1198±294 713±170 1261±168 20.29±4.24 10.67±1.32
OP NB 1893±582 369±44 697±217 19.58±3.985 6.10±1.64
OP OB 1067±156 520±78 992±66 20.20±2.97 11.02±0.35
Sample
4.3.6 The difference of trace elements between new bone and old bone  
Trace elements such as Fe, Zn, Sr, Ba and Pb between new bone and old bone were 
also detected by LA-ICP-MS and shown in Table 4, Fig. 16.  
The concentration of Fe in newly formed bone was significantly higher than that of 
old bone (p<0.05) in Sham group, and this trend was also shown in Ovx groups 
(p<0.05). The difference between Sham and Ovx groups was not obvious (Table 4, 
Fig. 16a). 
In both newly formed and old bone, the concentrations of Zn was higher in Sham 
groups than that of Ovx groups (p<0.05). The difference between newly formed bone 
and old bone in Sham group was significant (p<0.05), while there was no obvious 
difference found in Ovx group (p>0.05) (Table 4, Fig. 16b). 
The measurement of Sr in this study showed that the concentration of Sr was higher 
in older bone than in newly formed bone of both groups (p<0.05). In old bone Sham 
group had higher concentrations of Sr than that in Ovx group (p<0.05), while there 
was no significant difference between these two groups in newly formed bone 
(p>0.05) (Table 4, Fig. 16c). 
The detected concentrations of Ba were lower in newly formed bone than that of old 
bone of Sham group (p<0.05), while in Ovx group the concentrations were 
comparable (p>0.05). Sham group had a lower concentration of Ba in newly formed 
bone than Ovx groups (p<0.05), while the concentrations in old bone were 
comparable between both groups (p>0.05) (Table 4, Fig. 16d). 
The concentrations of Pb was higher in old bone than those in newly formed bone in 
both Sham and Ovx groups (p<0.05). No obvious difference was found between 
Sham and Ovx groups in both newly formed and old bone (p>0.05) (Table 4, Fig. 
16e). 
  
Table 4 Element distribution of each group measured by LA-ICP-MS. 
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Figure 16 Element distribution of each group measured by LA-ICP-MS. 
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Chapter 5: Discussion 
In this study, the osteoporosis models of rats were used to investigate the 
composition and structure of mineral of maxilla using advanced analytical facilities. 
The results demonstrate that the Ca/P ratio of new bone in maxilla region is 
comparable between Ovx group and Sham group, indicating the de novo bone may 
share compositional similarities with original bone. Furthermore, the SAED patterns 
of mineral crystal show that mono crystallite may exist in Ovx group. These patterns 
differed from the Sham group in which the mineral distribution was continuous and 
evenly located within the collagen structure. The distribution of trace elements was 
also measured using LA-ICP-MS and the results showed that there were differences 
between Sham and Ovx groups. 
 
5.1 THE MINERAL COMPOSITION OF OSTEOPOROTIC MAXILLA  
Mature bones undergo continuous remodeling; this process generates heterogeneous 
distributions in mineralized tissues leading to uneven gradations of mineralization 
[174]. The degree of bone mineralization will influence bone quality in a critical 
manner and consequently affect mechanical properties [175]. Current research 
findings demonstrate that osteoporosis is largely correlated with absolute bone mass 
loss in tibia. However, the effect of estrogen deficiency on jaw bone quality is still 
considered controversial. Some research studies found no change in mineral content 
induced by Ovx treatment [176], while others detected an increase in the mineral 
content following estrogen deficiency [177-181]. The inorganic mineral components 
in calcified tissues play an important role in the strength of the tissues. This topic is 
often neglected by researchers, in particular, the chemical composition changes in 
bone mineral and its impact on the quality of bone [182].  
In this study, Ca/P ratio was applied as a key indicator, used to distinguish the bone 
quality. The relative amount of calcium and phosphate is critical for the maintenance 
of bone metabolism and mineral balance. Furthermore, the Ca/P correlation is 
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evident for bone development [183]. To investigate mineral composition, EDS was 
used in this study. EDS is a sensitive qualitative and semi-quantitative technique for 
the measurement of the differences in the mineral composition in microscopic view. 
Combining the EDS system with SEM, element analysis data was produced showing 
the weight, atomic percentage and distribution of selected elements. The Ca/P ratios 
of weight percentage of both newly formed and old bone were found to be similar 
between normal and osteoporosis groups. This result indicates that newly-formed 
bones may function in a similar way to the physiological bones because of the 
similarities in mineral composition between Ovx and Sham groups. The element 
distribution that correlated to bone mineral composition remained similar between 
Ovx and Sham group in this study. 
To confirm the results further, the Ca/P ratio was also measured using LA-ICP-MS 
which is considered a more accurate technique. The results obtained from the LA-
ICP-MS analysis further confirmed that there was no significant change of the 
mineral composition in maxilla between Sham and Ovx groups. 
 
5.2 THE DISTRIBUTION OF TRACE ELEMENTS IN OSTEOPOROTIC 
MAXILLA  
Apart from mineral composition and structure, trace elements are also 
considered important components of bone tissues and play a vital role in major 
metabolic pathways. Trace elements may also play a significant role in relation to the 
development of osteoporosis [184-188]. The differences of distribution of trace 
elements discussed in this project are mainly compared between long bone (tibia) 
and jaw bone (maxilla). As the jaw bone has distinct developmental origin and mode 
of ossification comparing to long bones, potential difference in the mineralization 
process in osteoporotic may be different between jaw bone and long bone [189]. And 
it is reported that failure rate in surgery such as dental implant is higher in maxilla 
than mandible suffering osteoporosis [190]. Therefore, maxilla bone is chosen as the 
research object to compare with tibia bone in this project. 
The relationship between osteoporosis and the distribution of bone atomic minerals 
in a site-dependent manner still remains unclear. This is especially true for tibia and 
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maxilla. In this study, ovariectomised rat was used as an effective animal model due 
to its similarity with human in bone loss with estrogen deficiency [191]. This study 
was the first to investigate the effects of ovariectomy-induced estrogen deficiency on 
the atomic mineral element distributions in tibial trabecular bones and maxillary 
cortical bones using LA-ICP-MS, with the aim of understanding the site-specific 
chemical compositions. The results demonstrated that overall, the average 
concentrations of 
25
Mg, 
28
Si, 
39
K, 
47
Ti, 
56
Fe, 
59
Co,
 66
Zn, 
77
Se, 
88
Sr, 
137
Ba, and 
208
Pb 
were higher in tibia than that in maxilla, indicating tibial trabecular bones are more 
sensitive to the change of estrogen level than maxillary cortical bones.  
Researchers have relied on the conventional approaches, such as histomorphometry 
[158, 192], micro-CT (µCT) [158, 193], dual-energy X-ray absorptiometry (DEXA) 
[194] and Raman spectroscopy [195] to analyse the changes  of bone quality induced 
by ovariectomy. However, no sufficient data with regard to the inorganic or organic 
element distributions have been revealed by the aforementioned methods.  In this 
study, LA-ICP-MS has been employed to determine the important role of atomic 
minerals in osteoporosis. LA-ICP-MS has a spatial resolution ranging about 10-100 
μm [122] and low detection limits from parts per million to parts per billion range 
[196]. All these benefits make it a versatile tool to quantify the elements in hard 
tissues, which will lead to a better understanding of the biomineralization processes 
[197-199].  
The ratio of calcium (Ca) and phosphorus (P) of bone has been used as an indicator 
of osteoporosis. Increased Ca intake has been shown to increase bone density [200], 
while  consumption of excess amounts of dietary P combined with a low Ca intake, 
leads to secondary hyperparathyroidism and progressive decrease in bone mineral 
contents [201]. In addition, the decrease of Ca/P ratio has been shown to be related 
with increasing bone turnover [202]. However, whether ovariectomy-induced 
estrogen deficiency affects Ca/P ratios remains a controversial issue. Zairin et al 
carried out X-Ray fluorescence analysis and found that there was no significant 
difference in the levels of Ca, P, Fe, Cu, Zn, Ni, Ca/P, and Cu/Zn between the Ovx 
and the Sham group one month and two months after the surgery [203]. However, 
other researchers found that ovariectomized rats showed a gradual but significant 
increase in serum calcium and phosphorus level [204]. Our study has applied the LA-
ICP-MS to investigate the element concentrations for resin-embedded tibia and 
maxilla with polished smooth surfaces. It was noted that ovariectomy-induced 
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estrogen deficiency decreased the Ca/P ratio in tibia; however, the difference was not 
obvious in maxilla. In this study, the amount of Fe, Zn, Sr, Co, Ba and Pb in newly 
formed and old bone in maxillary bone with LA-ICP-MS was respectively measured 
and the results indicate their involvement in the progression of the disease. 
It has been documented that up to 94% of the body burden of lead is in organic or 
inorganic forms in bone with a half-life of years to decades [205]. Lead is classified 
as a toxic metal and lead exposure increases the risk of hip fracture in both males and 
females [181]. Lead has been reported to inhibit calcium absorption and cellular 
function, and induce osteoporosis through inhibition of vitamin D [206]. 
Furthermore, lead can inhibit osteonectin calcium binding protein in vitro for 
osteoblasts [207]. In this study, the concentration of lead was significantly higher in 
both tibia and maxilla from the Ovx group than the Sham group over time. 
Interestingly, there was a higher concentration of 
208
Pb in tibia than in maxilla at all 
evaluated time points. It is believed that the excessive bounding of lead in 
osteoporotic tibia and maxilla could disturb cellular functions which would then 
produce an imbalance in bone resorption and bone formation. The result of Pb 
measuring newly formed and old bone in maxillary bone showed a higher 
concentration in old bone than newly formed bone in both Sham and Ovx groups 
which indicates the deposition of Pb in bone. No obvious difference was found 
between Sham and Ovx groups. 
Cobalt is a toxic metal for osteoblast in vitro and a high concentration of this metal 
induces osteoblast apoptosis [208]. In this study, cobalt in osteoporotic tibial 
trabecular bone was higher than in maxillary cortical bone at all time-points, which 
may result in the inhibition of bone formation and subsequently contribute to the 
imbalance condition between bone formation and resorption activity in long bone.  
Zinc and strontium have been demonstrated to be essential elements for normal bone 
growth and bone metabolism. Zn is an important element for bone health as it 
increases activity of osteoblast and inhibits osteoclast of bone resorption, promoting 
bone formation [209]. It has been demonstrated that Zn can increase bone density, 
and inhibit bone loss [205]. This element stimulates the mineralization of osteoid and 
has positive effects on the structure of bone matrix [210]. This study has shown a 
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deficiency of zinc in the osteoporotic maxillary bone. This may be the reason for 
imbalance between bone formation and resorption activity in osteoporosis.  
The concentration of Zn detected in maxilla of newly formed and old bone showed 
that the deficiency of zinc was found in the Ovx groups. This may indicate the 
imbalance of bone remodelling. The difference between newly formed bone and old 
bone in Sham group was significant, while this phenomenon was not shown in Ovx 
group. 
According to previous in vitro and in vivo studies, strontium has positive effects on 
bone metabolism, which can induce maturation of human osteoblast and the 
administration of low-dose strontium in rat can lead to bone formation [211, 212]. 
Some experiments have shown that low dose of Sr administration may reduce bone 
resorption and increase bone formation, resulting in increased bone mass in normal 
animals [213, 214]. It also indicates that Sr may have potential benefits in the 
treatment of osteopenia [186]. Previous research has shown that Sr administration 
significantly increased trabecular bone volume and thickness [215]. In this study, the 
level of strontium in osteoporotic tibial bone was generally higher than in the 
osteoporotic maxillary bone. However, there was a higher concentration of strontium 
detected in the maxilla from the Ovx group compared with the Sham group at all 
time-points post-surgery. The measurement of Sr in the newly formed and old bone 
shows that, in old bone, Sham group have a higher concentration of Sr than that in 
Ovx group, which indicates the involvement of Sr in bone formation. Furthermore, in 
both Sham and Ovx groups, the concentrations of Sr were higher in old bone. 
Ba is primarily deposited in active bone growth areas and is one of the atoms that can 
substitute calcium in hydroxyapatite that is found in the osteoporosis bone [216, 217]. 
An increase in Ba may be caused by age and bone remodeling [218]. In some 
research studies, Ba concentration was found to be higher in osteoporosis than in 
normal bones [217]. In this study, barium in osteoporotic maxillary bone was found 
higher than in normal maxillary bone; however, there was a higher concentration of 
137
Ba detected in tibia than in maxilla at all evaluated time-points. This data indicates 
that barium is involved in the imbalance between bone formation and resorption in 
osteoporosis. In this study, Ba in newly formed bone of Sham group was found to be 
significantly lower than that of either old bone in Sham group or newly formed bone 
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of Ovx group. The concentrations in old bone between Sham and Ovx groups were 
comparable. 
 
Fe is involved in the control of synthesis of bone matrix and through active vitamin 
D it stimulates calcium absorption. Previous research has revealed that rats suffering 
Fe deficiency had poorly mineralized skeletons and pathological changes in the 
microarchitecture of trabecular bone [185, 186]. Fe is also essential for the synthesis 
of collagen in bone formation [217]. Thus, the effect of Fe in the development of 
osteoporosis is worth mentioning [219]. The results obtained in this study show that 
the concentration of Fe was higher in newly formed bone than that of old bone which 
may indicate the role of Fe in bone formation. The difference between Sham and 
Ovx groups was not obvious. 
In summary, this study is the first to unveil the atomic minerals which play an 
important role in to the development of osteoporotic phenomena in a site-specific 
and time-dependent manner. The findings suggest the dietary intervention might be 
an alternative approach to prevent osteoporosis. 
 
5.3 THE STRUCTURE OF COLLAGEN AND MINERAL CRYSTAL IN 
OSTEOPOROTIC MAXILLARY BONE 
Bone quality is determined by its structural and material properties. 
Microarchitecture is classified as part of bone structural properties while mineral and 
collagen composition are included in bone material properties [220]. Collagen is an 
important factor for bone matrix. Increasing evidence suggests that in physiological 
condition, the mineral provides strength and stiffness while collagen also contributes 
to bone ductility with the ability of absorbing energy before bone fracture [220]. 
Collagen fibrils in bone act as a template for a highly organized arrangement of 
paralleled oriented mineral crystals [221].  
In this study, the TEM results show regular alignment of fibrils with the periodic 
banding characteristic of Type I collagen fibrils. The contrast of the bands is due to 
the presence of crystals of hydroxyapatite within the gap zones of the fibrils [222]. 
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The arc in a SAED pattern always represents the orientation of the crystal [171]. The 
orientation of mineral crystals was shown in this study from the SAED patterns. The 
parallel orientation of collagen and mineral in TEM images and SAED indicate 
ordered mineralization. However, the spots in the SAED patterns of Ovx group were 
observed adjacent to the similar rings shown in that of Sham groups. Normally, the 
SAED pattern from crystalline shows bright spots, the SAED pattern from the 
polycrystalline phase shows a series of rings, while the one shows spots is from 
mono crystallites [171]. The spots in the SAED patterns from Ovx groups indicate 
the mineral is mono crystallites in osteoporotic bones.  
 
5.4 THE APPLICATION OF ANALYTICAL FACILITIES AND 
EXPERIMENTAL CONDITIONS 
SEM is often used to observe surface morphology of specimens while the application 
of EDS allows in situ element measurement. In this study, EDS combined SEM was 
applied to measure the concentration of calcium and phosphate. The measurement of 
elements by EDS can be generated in the form of weight and atom percentage. 
Combining this process with SEM is very useful for the measurement of bone 
minerals at a small scale. However, the detection of trace elements with EDS is not 
sensitive enough.  
Using LA-ICP-MS, more sensitive measurement of trace elements can be achieved. 
Some difficulties were encountered in this study with resin embedded samples as the 
required scale for measurement could not be covered. Samples grounded into powder 
from fixed bone tissues may be more feasible in future work. In this study, a glass 
wafer standard reference material SRM NIST 612 glass was applied as standard. For 
specific measurement of bone tissues, a cost-effective and more accurate internal 
standard for the detection of trace elements is needed in further study.  
TEM samples were prepared by FIB as the resin embedded bone was unable to be 
cut into thin sections using microtome. The sample preparation by FIB was time-
consuming; however, there is an advantage in using this technique. The sites of 
interest can be easily selected under electron microscope which facilitates the 
efficient observation and comparison of samples under TEM. 
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Chapter 6: Conclusions 
This study shows that the main mineral composition may not change in the rat 
maxillary bone after Ovx; however, alterations may occur in the crystallization of 
bone mineral. Higher concentrations of Zn and Sr were detected in normal maxillary 
bone than osteoporotic bone. The concentrations of Zn, Sr and Pb were higher in old 
bone than in newly formed bone while the concentration of Fe was lower. The 
average concentrations of 
25
Mg, 
28
Si, 
39
K, 
47
Ti, 
56
Fe, 
59
Co, 
66
Zn, 
77
Se, 
88
Sr, 
137
Ba, and 
208
Pb were generally higher in tibia than those in maxilla with time. In addition, the 
concentrations of 
28
Si, 
77
Se, and
 208
Pb were higher in tibia and maxilla in osteoporotic 
rats than those in normal bone at all evaluated time-points. These varieties indicate 
the potential role that trace elements have in bone formation and metabolism; 
meanwhile, tibial trabecular bones are more sensitive to the change of estrogen than 
maxillary bones. 
The application of analytical facilities demonstrated both an effective and systemic 
analysis of element constitution and the structure of bone minerals. Specifically, 
SEM-EDS is fast and practical for the measurement of the main elements of bone 
mineral; LA-ICP-MS is sensitive and efficient for detecting the concentration of 
trace elements down to the ppm level; TEM is functional for the observation of 
collagen in bone at the nano level and SAED patterns can be applied to demonstrate 
the condition of bone mineral crystals. All of these methods and facilities can be 
successfully applied in the systematic characterization of bone mineralization. 
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Appendix A 
List of Publications and Presentations 
The following is a list of published, accepted or submitted manuscripts during 
the Master candidature:  
1. Shifeier Lu, Pingping Han, Zhibin Du, Qiliang Zuo, Ross Crawford, Yin 
Xiao. “Ultrastructural Analysis of Maxilla Bone Mineralization in Rat 
Osteoporosis Model.” (Manuscript in preparation) 
2. Jun Wang, Ali Kalhor, Shifeier Lu, Ross Crawford, Jiang-Dong Ni, Yin 
Xiao. “iNOS expression and osteocyte apoptosis in idiopathic, non-
traumatic osteonecrosis.” Acta orthopaedica 85, no. 6 (2014): 1-8. 
3. Qiliang Zuo, Thor Friis, Shifeier Lu, Zhibin Du, Ross Crawford, Jiangwu 
Yao, Yin Xiao. “Characterization of nano-structural and nano-mechanical 
properties of osteoarthritic subchondral bone.” (Under review) 
The following is a list of conference presentations during the Master 
candidature: 
1. Shifeier Lu, Pingping Han, Zhibin Du, Qiliang Zuo, Ross Crawford, Yin 
Xiao. “Ultrastructural Analysis of Maxilla Bone Mineralization in Rat 
Osteoporosis Model.” Asia-Pacific Tissue Engineering and Regenerative 
Medicine International Society (TERMIS-AP). 24th-27th September 2014, 
Daegu, Republic of Korea. Oral Presentation. 
2. Shifeier Lu, Pingping Han, Zhibin Du, Qiliang Zuo, Ross Crawford, Yin 
Xiao. “Analysis in Ultrastructure of Maxilla Bone Mineralization in Rat 
Ovx Model.” IHBI Inspires. 20th-21st November. Gold Coast, Australia. 
Poster Presentation. 
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3. Qiliang Zuo, Jiangwu Yao, Shifeier Lu, Zhibin Du, Wei Shi, Yin Xiao. 
“Protein-bound phosphate function in collagen mineralization.” Asia-
Pacific Tissue Engineering and Regenerative Medicine International 
Society (TERMIS-AP). 24th-27th September 2014, Daegu, Republic of 
Korea. Poster Presentation. 
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